Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative randomized double-blind in-situ study of saliva substitutes on enamel and dentin
2008-005451-23Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2009
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Glandosane in xerostomia (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Changes in enamel and dentin mineralization. Started Jan 2009; status: terminated.
02
Drugs
Glandosane
03
Conditions
xerostomia
Beyond the preview
Go deeper on 2008-005451-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005451-23.